Narasin

Basic Information

Item Value
DrugBank ID DB11432
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 28

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 interventricular septum aneurysm KG + DL
2 pulmonary valve disease KG + DL
3 orofacial clefting syndrome KG + DL
4 Laubry-Pezzi syndrome KG + DL
5 genetic syndromic Pierre Robin syndrome KG + DL
6 disorder of fucoglycosan synthesis KG + DL
7 partial deletion of the long arm of chromosome 22 KG + DL
8 Pierre Robin syndrome associated with a chromosomal anomaly KG + DL
9 Jeune syndrome situs inversus KG + DL
10 partial deletion of the long arm of chromosome 7 KG + DL
11 mitral valve disease KG + DL
12 heart disease KG + DL
13 heart neoplasm KG + DL
14 heart valve disease KG + DL
15 congenital anomaly of ventricular septum KG + DL
16 heart conduction disease KG + DL
17 pericardium disease KG + DL
18 patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome KG + DL
19 heart aneurysm KG + DL
20 cor biloculare KG + DL
21 cardiac anomalies-heterotaxy syndrome KG + DL
22 carcinoid heart disease KG + DL
23 myocardial rupture KG + DL
24 white forelock with malformations KG + DL
25 aortopulmonary window KG + DL
26 microcephaly-cardiac defect-lung malsegmentation syndrome KG + DL
27 cardiac ventricle disease KG + DL
28 tarp syndrome KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.